South Asia: OTC pharmaceuticals segment revenue

Over the last two observations, the revenue is forecast to significantly increase in all segments. Comparing the six different segments for the year 2027, the segment 'Cold & Cough Remedies' leads the ranking with 22.53 billion U.S. dollars. Contrastingly, 'Hand Sanitizer' is ranked last, with 1.42 billion U.S. dollars. Their difference, compared to Cold & Cough Remedies, lies at 21.11 billion U.S. dollars.

Find other insights concerning similiar markets and segments, such as a comparison of revenue growth in Mexico and a comparison of revenue in Southeast Asia.

Revenue of the OTC pharmaceuticals market in South Asia from 2018 to 2027, by segment (in billion U.S. dollars)

Characteristic	Cold & Cough Remedies	Vitamins & Minerals	Analgesics	Digestives & Intestinal Remedies	Skin Treatment	Hand Sanitizer
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-
-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

The Over-the-Counter Pharmaceuticals market comprises over-the-counter medicine that can be purchased without a medical prescription. The market is subdivided into Analgesics, Cold and Cough Medication, Digestives and Intestinal Remedies, Skin Treatment products and Vitamins and Minerals. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Citation formats